This year's HLTH conference brought a bevy of news announcements — from partnerships to new product features to acquisitions and more. In this list, MedCity News compiled short summaries for 11 of the conference's most notable announcements.
Bessemer Venture Partners and Columbia Capital led the round, and Blue Heron Capital and California Health Care Foundation also participated.
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases
Bessemer Venture Partners and Columbia Capital co-led the investment round. Both had participated in Verato's Series A in 2015.